Response to interleukin-4

pathway activity — cross-omics
GO:0070670Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Response to interleukin-4 pathway is significantly associated with the RNA expression of multiple genes, with the GBM cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are MEFV, CRTAM, and PTPN22, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Response to interleukin-4 activity versus MEFV in GBM (Pearson r = 0.22).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
GBMMEFV →+0.626+0.171<.001<.00135
COADCRTAM →+0.621+0.142<.001.00135
HNSCPTPN22 →+0.567+0.153.008.00434
LUADCLEC4D →+0.529+0.195<.001<.00134
OVSAA1 →+1.657+0.214.008<.00134
GBMJAK3 →+1.047+0.235<.001<.00134
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0070670 vs MEFV — GBM

Per-sample scatter of Response to interleukin-4 activity vs MEFV in GBM.

Explore this scatter interactively →

Exploration